These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15932746)

  • 21. Immunohistochemical study on liver fibrosis in biliary atresia.
    Murata K; Kamata Y; Munakata H; Sugai M; Sasaki M
    Hepatogastroenterology; 2008; 55(81):179-83. PubMed ID: 18507102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Large hepatitis delta antigen modulates transforming growth factor-beta signaling cascades: implication of hepatitis delta virus-induced liver fibrosis.
    Choi SH; Jeong SH; Hwang SB
    Gastroenterology; 2007 Jan; 132(1):343-57. PubMed ID: 17241884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Migration of hepatic stellate cells in fibrotic microenvironment of diseased liver model.
    Chang YZ; Yang L; Yang CQ
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):401-5. PubMed ID: 18693176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads.
    Weng H; Mertens PR; Gressner AM; Dooley S
    J Hepatol; 2007 Feb; 46(2):295-303. PubMed ID: 17125875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remote delivery and expression of soluble type II TGF-beta receptor in muscle prevents hepatic fibrosis in rats.
    Nakamuta M; Morizono S; Tsuruta S; Kohjima M; Kotoh K; Enjoji M
    Int J Mol Med; 2005 Jul; 16(1):59-64. PubMed ID: 15942678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage.
    Dooley S; Hamzavi J; Ciuclan L; Godoy P; Ilkavets I; Ehnert S; Ueberham E; Gebhardt R; Kanzler S; Geier A; Breitkopf K; Weng H; Mertens PR
    Gastroenterology; 2008 Aug; 135(2):642-59. PubMed ID: 18602923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation.
    Fu Y; Zheng S; Lin J; Ryerse J; Chen A
    Mol Pharmacol; 2008 Feb; 73(2):399-409. PubMed ID: 18006644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutical targets for revert liver fibrosis].
    García B L; Gálvez G J; Armendáriz B J
    Rev Med Chil; 2007 Jun; 135(6):783-91. PubMed ID: 17728907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of ribozyme against transforming growth factorbeta1 on biological character of activated HSCs.
    Song YH; Zhou XM; Xue XN; Liu NZ; Tian DA; Kong XJ; Wu XL; Lin JS; Jin YX
    IUBMB Life; 2005 Jan; 57(1):31-9. PubMed ID: 16036560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Multi-peptides growth factor expression in asthma model rats and effect of dexamethasone on its expressions].
    Pan P; Wu E; Chen Q; Yin B; Hu C; Chen Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Nov; 23(11):696-7, 27. PubMed ID: 11225040
    [No Abstract]   [Full Text] [Related]  

  • 31. [Strengthen the study on the relation between cytokines and glomerulosclerosis].
    Chen X
    Zhonghua Yi Xue Za Zhi; 1996 Jun; 76(6):403-4. PubMed ID: 9275478
    [No Abstract]   [Full Text] [Related]  

  • 32. [Targeted glycyrrhetinic acid to receptors of hepatic stellate cells for the treatment of rat liver fibrosis: a pilot study].
    Zhang QS; Yuan RH; Zhang J; Tian GY
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):512. PubMed ID: 15329226
    [No Abstract]   [Full Text] [Related]  

  • 33. [Advances in basic and clinical research on liver fibrogenesis].
    Jia JD; Wu XN
    Zhonghua Gan Zang Bing Za Zhi; 2008 Mar; 16(3):161-2. PubMed ID: 18364066
    [No Abstract]   [Full Text] [Related]  

  • 34. Closing in on the signals of hepatic fibrosis.
    Friedman SL
    Gastroenterology; 1997 Apr; 112(4):1406-9. PubMed ID: 9098030
    [No Abstract]   [Full Text] [Related]  

  • 35. [Detection of platelet-derived growth factor-AB in patients'sera with hepatic cirrhosis pre- and post- splenectomy].
    Chen LM; Wang LJ; Zhang HF; Cheng Y; Xin SJ; Chen JM; Zhang XF
    Zhonghua Gan Zang Bing Za Zhi; 2003 Dec; 11(12):748. PubMed ID: 14697139
    [No Abstract]   [Full Text] [Related]  

  • 36. [Growth factors and wound healing].
    Wang Y; He Q; Li Z; Jiang H
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1999 Nov; 15(6):462-4. PubMed ID: 11501088
    [No Abstract]   [Full Text] [Related]  

  • 37. Endothelin in hepatic fibrosis--friend or foe?
    Rockey D
    Hepatology; 1996 Jun; 23(6):1698-700. PubMed ID: 8675196
    [No Abstract]   [Full Text] [Related]  

  • 38. [Molecular and cellular mechanism of fat-storing cell activation].
    Liang ZQ; He ZP
    Sheng Li Ke Xue Jin Zhan; 1998 Oct; 29(4):364-6. PubMed ID: 12501672
    [No Abstract]   [Full Text] [Related]  

  • 39. Protease inhibitors suppress TGF-beta generation by hepatic stellate cells.
    Okuno M; Moriwaki H; Muto Y; Kojima S
    J Hepatol; 1998 Dec; 29(6):1031-2. PubMed ID: 9875655
    [No Abstract]   [Full Text] [Related]  

  • 40. Perspectives in the treatment of liver fibrosis.
    Mavier P; Mallat A
    J Hepatol; 1995; 22(2 Suppl):111-5. PubMed ID: 7665845
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.